Chemoinformaics analysis of 7-METHOXY-4-PHENYL-2H-CHROMEN-6-OL
| Molecular Weight | 254.285 | nRot | 2 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 17 |
| Exact Molecular Weight | 254.094 | nRing | 3 |
| Solubility: LogS | -3.961 | nHRing | 1 |
| Solubility: LogP | 3.214 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 38.4611 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.894 |
| Synth | 2.301 |
| Natural Product Likeliness | 1.42 |
| NR-PPAR-gamma | 0.136 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.38 |
| Pgp-sub | 0.815 |
| HIA | 0.005 |
| CACO-2 | -4.958 |
| MDCK | 0.0000156 |
| BBB | 0.362 |
| PPB | 0.968081 |
| VDSS | 0.884 |
| FU | 0.0300712 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.926 |
| CYP2c19-inh | 0.805 |
| CYP2c19-sub | 0.214 |
| CYP2c9-inh | 0.639 |
| CYP2c9-sub | 0.817 |
| CYP2d6-inh | 0.704 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.473 |
| CYP3a4-sub | 0.592 |
| CL | 11.901 |
| T12 | 0.63 |
| hERG | 0.248 |
| Ames | 0.071 |
| ROA | 0.767 |
| SkinSen | 0.605 |
| Carcinogencity | 0.658 |
| EI | 0.013 |
| Respiratory | 0.444 |
| NR-Aromatase | 0.132 |
| Antiviral | No |
| Prediction | 0.657452 |